Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

Findings from a new medical trial, recently published in a prestigious scientific journal, may significantly improve life outcomes for patients with high-risk myeloma.

HIMSS22 Europe: ‘We need to co-create and work together with patients’

“I want to convince you in the next few minutes that I’m part of the solution, not necessarily just a problem,” Graham Prestwich, public and

June 15, 2023

Amyloid-β and tau disrupt brain activity, driving early cognitive decline in Alzheimer’s risk

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive decline in older adults at risk of Alzheimer’s disease.

September 20, 2024

Study challenges finding that Black babies are more likely to survive under the care of Black physicians

New research calls into question the high-profile conclusion of the first major study to show that the race of physicians influences health outcomes. In August

October 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.